Jun 12, 2019
The study published in The New England Journal of Medicine set out to study the effect of the drug teplizumab in people at high risk for type 1 diabetes. According to recent Phase II clinical trials, in experimental immunotherapy conducted, the drug has been able to delay the onset of disease for the first tim...
Read More...
Nov 14, 2018
[caption id="attachment_3594" align="aligncenter" width="1360"] World Diabetes Day[/caption] Today we celebrate World Diabetes Day to raise global awareness of a disease that affects million people worldwide. In honor of this day, we have garnered myths & facts about diabetes.
Read More...
Nov 14, 2018
[caption id="attachment_3575" align="aligncenter" width="1360"] World Diabetes Day[/caption] Caring for Diabetes involves family too. Education and awareness play the most important role in early diagnosis and management. World Diabetes Day is celebrated on 14 November each year.
Read More...
Sep 26, 2018
Functional β-cell mass loss leads to the pathogenesis of type 1 diabetes mellitus (T1DM) and also adds to type 2 diabetes mellitus (T2DM). Genetically induced downregulation of Arx, a key transcription factor for glucagon-producing α-cell specification and phenotype, in α-cells converts them into insulin-producing β...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Newsletter/Whitepaper